Genres: YA; Dystopia; Science Fiction
My rating: 4 stars
Average Goodreads rating: 3.98 stars
They thought the Maze was over...but it had just begun.
Thomas and the remaining Gladers escaped the Maze expecting relief. What they got was another test from the people they were quickly coming to despise—WICKED.
Now surrounded by crazed people infected with a deadly disease, they must race to get the cure or perish with everyone else.
They were told WICKED was good. But can they really trust them? It may be their only option.
Let the Scorch Trials begin.
My review: Out of the frying pan and into the fire—that's how it was for Thomas and the gang when they completed the deadly Maze. Only to find themselves in yet another predicament they'd be hardpressed to survive.
I thought this was a good follow-up to The Maze Runner. It was paced faster, and more exciting, in my opinion. The stakes were higher—everyone's life was on the line if they didn't reach that cure.
I liked the addition of new characters. The boys' story continues, but we're also introduced to Jorge and Brenda, two “cranks” plagued by the disease. And Group B—the group of girls who had just escaped from their own Maze. With all of these new characters we saw teamwork, yes. But also a lot of trust issues and fighting—lots of conflict that really spiced things up.
Like I said, there was a lot more excitement in The Scorch Trials, although I did feel that there was just something missing. I would have liked to see more character development, especially with the secondary characters. And maybe something more could have been added to the plot. Also, I didn't really care for the romance between Thomas and Teresa, but that really didn't take away any of my enjoyment.
Overall, I really liked this book and will definitely want to read the rest of the series. I love the epilogues and glimpse they give of what WICKED is trying to do.
Content: One or two uses of profanity; some made up words used in place of cursing; kissing.
Click here to read my review of The Maze Runner.